Targeted therapy with anlotinib for patient with recurrent glioblastoma: A case report and literature review

RATIONALE: Glioblastoma (GBM) is the most aggressive malignant brain tumor in adults. The first choice for GBM is surgery, and followed by a combination of radiotherapy and chemotherapy. There are limited treatments for patients with recurrent GBM. Relapsed patients usually have a worse prognosis, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yajuan, Zhang, Jiandong, Liu, Fengjun, Song, Meijuan, Hou, Yong, Liang, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708909/
https://www.ncbi.nlm.nih.gov/pubmed/31145289
http://dx.doi.org/10.1097/MD.0000000000015749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708909/
https://www.ncbi.nlm.nih.gov/pubmed/31145289
http://dx.doi.org/10.1097/MD.0000000000015749

Ejemplares similares